Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Ashland › NPI 1851346720
Clinic

Ashland Hospital Corporation

Ashland Hospital Corporation was paid $222.76M by Medicaid between Jan 2018 and Dec 2024, across 794 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 11% of everything it billed.

33Billing provider infoASHLAND HOSPITAL CORPORATION
ASHLAND, KY 41101
33aNPI1851346720assigned 05/22/2006
33bProvider typeRural Health Clinic/Center
28Total paid$222.76M
24GClaims6,507,603
24DCodes billed794
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Health Clinic/Center providers in Kentucky

Rank by total paid#1 of 265
Median peer was paid$400K
This provider vs. median557×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MARKS, SARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M$6.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018643,069$23.96M
2019659,562$22.51M
2020687,447$23.78M
20211,000,133$34.33M
20221,100,101$37.51M
20231,274,562$42.60M
2024incomplete1,142,729$38.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11% 800,710 679,877 $24.50M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.0% 499,500 411,957 $17.81M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.7% 152,837 126,724 $10.52M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.3% 49,198 33,119 $9.52M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.4% 61,569 45,006 $7.51M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.8% 35,592 20,042 $6.21M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.6% 358,800 267,474 $5.80M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.8% 9,927 8,389 $4.10M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.8% 9,764 4,913 $3.95M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.7% 10,383 6,478 $3.83M
74176 Computed tomography, abdomen and pelvis; without contrast material 1.5% 11,537 9,223 $3.44M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 11,961 10,666 $3.23M
782 more codes
47562 1.2% 1,849 $2.67M
93458 1.2% 3,961 $2.66M
G0378 Hospital observation service, per hour <1% 14,483 $2.23M
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 17,905 $2.18M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 118,693 $2.16M
J2357 Injection, omalizumab, 5 mg <1% 4,767 $2.14M
80053 Comprehensive metabolic panel <1% 290,153 $2.07M
71046 Radiologic examination, chest; 2 views <1% 46,765 $2.01M
70450 Computed tomography, head or brain; without contrast material <1% 10,963 $1.82M
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 4,752 $1.75M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 29,024 $1.73M
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 3,700 $1.72M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 2,213 $1.52M
80050 General health panel <1% 25,622 $1.43M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 2,585 $1.43M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,992 $1.29M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 31,695 $1.28M
99203 Doctor's office visit, new patient (routine) <1% 42,431 $1.28M
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 143,662 $1.22M
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 227,370 $1.20M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 19,869 $1.18M
70551 Magnetic resonance imaging, brain; without contrast material <1% 3,298 $1.15M
71250 <1% 6,861 $1.15M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 35,307 $1.12M
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 31,991 $1.12M
77067 Screening mammography, bilateral, including computer-aided detection <1% 11,559 $1.09M
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 7,256 $1.07M
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 49,422 $1.07M
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 918 $1.05M
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 50,607 $1.03M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 11,002 $1.02M
90460 Immunization administration through 18 years of age via any route, first or only component <1% 29,340 $1.02M
72141 <1% 2,356 $989K
96361 Intravenous infusion, hydration; each additional hour <1% 28,092 $965K
62323 <1% 2,095 $960K
95811 <1% 1,459 $956K
58571 <1% 423 $953K
93017 <1% 6,003 $938K
58661 <1% 524 $926K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 31,653 $879K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,757 $879K
76536 <1% 4,460 $866K
95911 <1% 1,451 $858K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 100,465 $847K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 14,945 $842K
74018 <1% 9,543 $834K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,964 $814K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 51,853 $788K
72100 <1% 8,646 $781K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 1,191 $778K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 11,214 $760K
36415 Collection of venous blood by venipuncture <1% 244,515 $734K
96375 Therapeutic injection; each additional sequential IV push <1% 26,432 $718K
71045 Radiologic examination, chest; single view <1% 31,401 $715K
80061 Lipid panel <1% 71,258 $698K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,920 $687K
73630 <1% 11,488 $681K
S9128 Speech therapy, in the home, per diem <1% 9,415 $659K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,555 $656K
84443 Thyroid stimulating hormone (TSH) <1% 54,607 $652K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 11,807 $645K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 31,840 $634K
73610 <1% 9,808 $620K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 10,125 $611K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 4,081 $609K
J9271 Injection, pembrolizumab, 1 mg <1% 140 $608K
73030 <1% 10,140 $584K
93226 <1% 4,185 $577K
73130 <1% 9,401 $570K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 83,570 $563K
73562 <1% 8,127 $547K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 12,306 $530K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 40,826 $502K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 14,375 $487K
73110 <1% 7,899 $486K
95886 <1% 3,034 $484K
0223U <1% 2,246 $484K
90461 <1% 14,655 $480K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 18,068 $460K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 8,230 $454K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg <1% 403 $448K
80048 Basic metabolic panel (calcium, ionized) <1% 68,808 $445K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,031 $431K
00731 <1% 4,596 $418K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 6,952 $417K
D2930 Prefabricated stainless steel crown - primary tooth <1% 764 $414K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 15,506 $411K
95909 <1% 1,344 $409K
96367 <1% 10,425 $396K
82607 <1% 34,977 $395K
70486 <1% 1,679 $391K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 11,006 $390K
72125 Computed tomography, cervical spine; without contrast material <1% 2,350 $383K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 13,159 $377K
93971 <1% 3,659 $375K
52000 <1% 1,378 $373K
S9129 Occupational therapy, in the home, per diem <1% 5,577 $372K
94060 <1% 4,468 $369K
93225 <1% 3,218 $361K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 13,064 $357K
49083 <1% 1,127 $351K
78227 <1% 752 $343K
00813 <1% 3,682 $339K
87902 <1% 1,854 $337K
83036 Hemoglobin; glycosylated (A1C) <1% 48,453 $333K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 14,684 $332K
76775 <1% 2,417 $332K
87086 Culture, bacterial; quantitative colony count, urine <1% 52,464 $331K
84484 <1% 33,612 $306K
73560 <1% 7,518 $305K
30140 <1% 360 $301K
00840 <1% 2,936 $297K
73221 <1% 855 $291K
99204 Doctor's office visit, new patient (more involved) <1% 16,958 $288K
76830 Ultrasound, transvaginal <1% 2,867 $286K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,307 $280K
95885 <1% 1,763 $276K
88342 <1% 4,097 $270K
84439 <1% 33,164 $266K
99173 <1% 10,219 $260K
80074 <1% 8,160 $255K
J7120 Ringers lactate infusion, up to 1000 cc <1% 31,968 $254K
72040 <1% 4,281 $252K
82947 <1% 35,170 $246K
96415 <1% 3,073 $243K
88341 <1% 1,842 $242K
00170 Anesthesia for intraoral procedures, including biopsy <1% 2,500 $240K
96376 <1% 12,388 $236K
70496 <1% 831 $233K
76642 <1% 2,407 $233K
73080 <1% 3,895 $231K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 9,871 $227K
86003 <1% 3,069 $227K
78816 <1% 293 $226K
97162 <1% 6,875 $224K
93975 <1% 1,462 $221K
70498 <1% 782 $215K
77066 Tomosynthesis, mammo <1% 1,794 $213K
72070 <1% 3,034 $209K
S9131 Physical therapy; in the home, per diem <1% 3,422 $209K
99215 Doctor's office visit, returning patient (complex) <1% 6,640 $209K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 7,554 $205K
00126 <1% 1,568 $201K
95816 <1% 1,063 $198K
94010 <1% 2,331 $197K
94729 <1% 3,291 $196K
74183 <1% 430 $196K
J2785 Injection, regadenoson, 0.1 mg <1% 3,305 $194K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,768 $192K
00811 <1% 1,902 $190K
71101 <1% 2,987 $190K
93880 <1% 1,064 $187K
84145 <1% 12,519 $187K
87522 Neg quan hep c or qual rna <1% 4,995 $186K
88307 <1% 2,279 $183K
90791 Psychiatric diagnostic evaluation <1% 3,551 $180K
94726 <1% 2,850 $178K
43235 <1% 524 $177K
00790 <1% 1,655 $174K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 6,294 $174K
29580 <1% 3,234 $174K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 825 $173K
36591 <1% 9,901 $166K
77065 Tomosynthesis, mammo <1% 2,048 $159K
30520 <1% 228 $157K
97597 <1% 5,011 $153K
85610 <1% 41,579 $153K
82728 <1% 15,414 $151K
J0897 Injection, denosumab, 1 mg <1% 585 $149K
83880 <1% 9,063 $149K
77063 Screening digital breast tomosynthesis, bilateral <1% 13,068 $147K
73502 <1% 5,390 $147K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 8,326 $146K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 672 $143K
73620 <1% 1,903 $143K
83735 <1% 34,844 $143K
93970 <1% 563 $142K
J2469 Injection, palonosetron hcl, 25 mcg <1% 2,418 $140K
52310 <1% 211 $139K
J7030 Infusion, normal saline solution , 1000 cc <1% 33,332 $139K
73590 <1% 2,700 $136K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 7,413 $136K
86235 <1% 3,427 $132K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 4,462 $131K
64721 <1% 140 $131K
81001 <1% 53,263 $129K
74178 <1% 194 $128K
58558 <1% 119 $128K
97803 <1% 4,234 $126K
99152 <1% 2,310 $126K
86703 <1% 10,045 $126K
90792 Psychiatric diagnostic evaluation with medical services <1% 2,003 $124K
87081 <1% 18,452 $123K
J2704 Injection, propofol, 10 mg <1% 46,125 $123K
76870 <1% 1,022 $123K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 4,678 $122K
83550 <1% 17,480 $121K
83605 <1% 16,367 $119K
74022 <1% 1,273 $118K
88304 <1% 3,308 $116K
74450 <1% 710 $112K
92557 <1% 3,091 $111K
73140 <1% 2,186 $109K
0225U <1% 569 $107K
86803 <1% 9,558 $106K
72131 <1% 926 $106K
92551 <1% 10,179 $105K
87150 <1% 3,535 $102K
83690 <1% 19,179 $101K
84703 <1% 21,564 $100K
73090 <1% 2,050 $99K
77080 <1% 2,019 $99K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 8,120 $99K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 189 $98K
D7140 Extraction, erupted tooth or exposed root <1% 464 $98K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,483 $97K
71271 <1% 1,944 $97K
78264 <1% 439 $96K
86850 <1% 10,182 $96K
93016 <1% 7,197 $94K
87505 <1% 1,103 $93K
93308 <1% 561 $93K
87186 <1% 14,508 $93K
81025 <1% 11,627 $92K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 65,027 $92K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,639 $92K
86140 <1% 19,484 $92K
97802 <1% 2,162 $91K
82746 <1% 7,858 $90K
75574 <1% 358 $87K
86780 <1% 8,515 $86K
96417 <1% 1,794 $85K
84702 <1% 7,029 $82K
86480 <1% 1,869 $81K
00910 <1% 721 $80K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 161 $79K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 260 $77K
91200 <1% 1,344 $77K
86900 <1% 12,402 $77K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 9,490 $75K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,891 $75K
00160 <1% 611 $72K
84153 <1% 5,439 $70K
84403 <1% 3,514 $69K
83970 <1% 2,587 $69K
87807 <1% 10,980 $68K
85730 <1% 16,892 $68K
87631 <1% 590 $68K
99442 <1% 2,533 $67K
70491 <1% 314 $67K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 32,180 $67K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,112 $67K
87040 <1% 7,990 $67K
64493 <1% 443 $66K
76819 Fetal biophysical profile; without non-stress testing <1% 397 $66K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 244 $65K
95806 <1% 676 $63K
87340 <1% 7,076 $62K
52281 <1% 141 $62K
99441 <1% 3,674 $62K
87070 <1% 8,535 $62K
93018 <1% 6,456 $61K
J3490 Unclassified drugs <1% 6,553 $61K
00812 <1% 550 $61K
J1756 Injection, iron sucrose, 1 mg <1% 2,577 $60K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 384 $60K
99238 Hospital discharge day management, 30 minutes or less <1% 1,283 $60K
99460 <1% 1,293 $60K
86762 <1% 5,053 $59K
85379 <1% 9,807 $59K
95913 <1% 71 $58K
93922 <1% 682 $58K
81003 <1% 46,453 $58K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,612 $58K
74246 <1% 818 $57K
96368 <1% 2,497 $57K
J1453 Injection, fosaprepitant, 1 mg <1% 1,872 $56K
73521 <1% 773 $56K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 36,195 $56K
82077 <1% 6,566 $55K
86376 <1% 4,553 $55K
27096 <1% 100 $55K
86901 <1% 9,968 $53K
88300 <1% 2,174 $52K
J0690 Injection, cefazolin sodium, 500 mg <1% 10,711 $52K
82043 <1% 11,166 $51K
J1644 Injection, heparin sodium, per 1000 units <1% 11,404 $51K
62321 <1% 96 $51K
99308 Subsequent nursing facility care, per day, straightforward <1% 10,284 $51K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 819 $51K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 151 $48K
J7050 Infusion, normal saline solution, 250 cc <1% 10,615 $47K
86038 <1% 4,647 $47K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 45,031 $47K
97166 <1% 1,373 $47K
97161 <1% 1,453 $47K
36430 <1% 336 $46K
86160 <1% 4,267 $45K
10060 <1% 676 $45K
96411 <1% 767 $44K
85652 <1% 17,680 $44K
82803 <1% 3,870 $44K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 4,076 $43K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 388 $43K
73120 <1% 661 $43K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 839 $42K
92567 <1% 2,294 $42K
72158 <1% 99 $42K
58662 <1% 25 $41K
83655 <1% 3,484 $41K
P9016 Red blood cells, leukocytes reduced, each unit <1% 898 $40K
83525 <1% 4,121 $40K
36561 <1% 51 $40K
87077 <1% 6,317 $39K
82140 <1% 3,736 $39K
82785 <1% 2,352 $38K
20610 <1% 825 $38K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 9,599 $38K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 82 $37K
86800 <1% 2,908 $37K
95910 <1% 92 $37K
C1769 Guide wire <1% 710 $37K
00952 <1% 316 $36K
87493 <1% 1,493 $36K
80076 <1% 5,182 $36K
96523 <1% 1,272 $36K
74019 <1% 684 $35K
88313 <1% 249 $35K
83516 <1% 2,591 $34K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 562 $34K
80069 <1% 6,507 $33K
00300 <1% 379 $32K
74174 <1% 90 $31K
90688 <1% 3,203 $31K
64494 <1% 193 $31K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 6,098 $31K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 24 $30K
83001 <1% 1,945 $30K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 4,055 $30K
84481 <1% 2,151 $30K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 172 $29K
72146 <1% 66 $29K
72156 <1% 42 $29K
J1437 Injection, ferric derisomaltose, 10 mg <1% 29 $28K
C1781 Mesh (implantable) <1% 302 $28K
87427 <1% 2,648 $28K
54150 <1% 402 $27K
84270 <1% 1,653 $27K
90756 <1% 1,997 $27K
84146 <1% 1,603 $26K
58563 <1% 13 $26K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 135 $25K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 712 $25K
10005 <1% 85 $25K
82550 <1% 4,178 $24K
82784 <1% 3,954 $24K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,905 $24K
97804 <1% 708 $24K
87430 <1% 4,137 $23K
77062 <1% 1,798 $23K
84436 <1% 3,884 $23K
93660 <1% 202 $22K
87205 <1% 5,582 $22K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 234 $22K
43249 <1% 83 $22K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 4,501 $21K
82570 <1% 5,239 $21K
76882 <1% 273 $21K
84550 <1% 5,315 $21K
73060 <1% 496 $21K
96416 <1% 372 $21K
82274 <1% 1,879 $21K
00400 <1% 272 $21K
84100 <1% 5,570 $21K
86706 <1% 2,292 $21K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 2,715 $20K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 120 $20K
70470 <1% 143 $20K
84132 <1% 2,391 $20K
86200 <1% 2,019 $20K
84681 <1% 1,209 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 84 $20K
86430 <1% 4,021 $20K
72170 <1% 707 $20K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 343 $20K
86225 <1% 1,853 $19K
87899 <1% 1,466 $19K
86696 <1% 1,242 $19K
90832 Psychotherapy session, about 30 minutes <1% 575 $19K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 28 $19K
86665 <1% 1,102 $18K
87328 <1% 1,562 $18K
80143 <1% 2,264 $18K
C1729 Catheter, drainage <1% 1,201 $18K
84144 <1% 1,054 $18K
92523 <1% 343 $18K
93312 <1% 70 $18K
J3475 Injection, magnesium sulfate, per 500 mg <1% 3,375 $18K
77061 <1% 1,712 $17K
82150 <1% 2,990 $17K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 221 $17K
80047 <1% 1,679 $17K
99205 Prolong outpt/office vis <1% 1,195 $17K
12001 <1% 356 $17K
84156 <1% 5,338 $17K
82950 <1% 3,936 $17K
80179 <1% 2,167 $17K
90686 <1% 7,105 $16K
76937 <1% 94 $16K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 26,625 $16K
86695 <1% 1,426 $16K
88185 <1% 65 $16K
86364 <1% 1,548 $16K
86258 <1% 1,423 $16K
74230 <1% 152 $16K
99443 <1% 346 $16K
83883 <1% 1,015 $16K
86255 <1% 1,688 $15K
82131 <1% 862 $15K
84480 <1% 1,323 $15K
80305 <1% 1,301 $15K
92587 <1% 340 $15K
87641 <1% 710 $15K
51701 <1% 784 $15K
72220 <1% 265 $14K
73700 <1% 100 $14K
87338 <1% 1,248 $14K
86708 <1% 1,488 $14K
80339 <1% 620 $14K
77002 <1% 69 $14K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 622 $14K
99406 <1% 2,114 $13K
87045 <1% 1,708 $13K
84207 <1% 698 $13K
87329 <1% 1,464 $13K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 10,207 $13K
70360 <1% 181 $13K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 2,123 $13K
72050 <1% 162 $13K
86141 <1% 1,252 $13K
01810 <1% 138 $12K
86618 <1% 888 $12K
83002 <1% 878 $12K
J0640 Injection, leucovorin calcium, per 50 mg <1% 857 $12K
90670 <1% 5,713 $12K
86757 <1% 706 $12K
88112 <1% 309 $12K
82565 <1% 1,464 $12K
J3480 Injection, potassium chloride, per 2 meq <1% 2,172 $12K
90715 <1% 2,143 $12K
96127 <1% 3,854 $12K
C1760 Closure device, vascular (implantable/insertable) <1% 293 $11K
99305 <1% 599 $11K
80164 <1% 1,208 $11K
12002 <1% 233 $11K
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 1,484 $11K
84425 <1% 597 $11K
86704 <1% 1,135 $11K
76010 <1% 780 $11K
73551 <1% 596 $10K
83615 <1% 2,385 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 245 $10K
85027 <1% 1,563 $10K
83993 <1% 606 $10K
80334 <1% 322 $10K
80337 <1% 321 $10K
88302 <1% 443 $10K
72128 <1% 52 $9K
42830 <1% 26 $9K
73000 <1% 175 $9K
72202 <1% 156 $9K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 929 $9K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,812 $9K
77001 <1% 62 $9K
86664 <1% 666 $9K
82533 <1% 633 $9K
82977 <1% 1,432 $8K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 2,831 $8K
C9046 Cocaine hydrochloride nasal solution (goprelto), 1 mg <1% 109 $8K
76942 <1% 40 $8K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 6,063 $8K
82103 <1% 662 $8K
87640 <1% 722 $8K
82172 <1% 473 $8K
72110 <1% 70 $8K
82248 <1% 1,850 $8K
97032 <1% 394 $8K
J2805 Injection, sincalide, 5 micrograms <1% 202 $8K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 2,868 $7K
83520 <1% 762 $7K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 9,050 $7K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 225 $7K
97116 <1% 369 $7K
84165 <1% 988 $7K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 32 $7K
A9585 Injection, gadobutrol, 0.1 ml <1% 229 $7K
86812 <1% 330 $7K
83010 <1% 686 $7K
72082 <1% 35 $7K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 130 $7K
84112 <1% 222 $7K
97012 <1% 548 $7K
64495 <1% 52 $7K
C1776 Joint device (implantable) <1% 13 $6K
86769 <1% 212 $6K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,575 $6K
93798 <1% 258 $6K
82105 <1% 554 $6K
92526 <1% 246 $6K
J1815 Injection, insulin, per 5 units <1% 2,816 $6K
J0692 Injection, cefepime hydrochloride, 500 mg <1% 2,981 $6K
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml <1% 40 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 400 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,789 $6K
82247 <1% 1,155 $6K
88173 <1% 85 $6K
97035 <1% 186 $6K
87210 <1% 996 $5K
98960 <1% 181 $5K
86147 <1% 210 $5K
41899 Unlisted procedure, dentoalveolar structures <1% 15 $5K
99307 <1% 1,539 $5K
72072 <1% 62 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,529 $5K
94727 <1% 154 $5K
86039 <1% 482 $5K
82525 <1% 546 $5K
82378 <1% 374 $5K
73718 <1% 14 $5K
J0248 Injection, remdesivir, 1 mg <1% 32 $5K
82670 <1% 218 $5K
64615 <1% 52 $4K
96160 <1% 2,393 $4K
82024 <1% 176 $4K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,406 $4K
J9190 Injection, fluorouracil, 500 mg <1% 858 $4K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,787 $4K
80370 <1% 112 $4K
84432 <1% 359 $4K
72120 <1% 93 $4K
82010 <1% 902 $4K
C2617 Stent, non-coronary, temporary, without delivery system <1% 134 $4K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 143 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 14 $4K
90837 Psychotherapy session, about an hour <1% 95 $4K
86923 <1% 523 $4K
29515 <1% 243 $4K
87581 <1% 209 $4K
90733 <1% 51 $4K
99201 <1% 84 $4K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,036 $4K
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care <1% 539 $4K
86308 <1% 961 $4K
00902 <1% 46 $4K
90853 Group psychotherapy (other than of a multiple-family group) <1% 184 $4K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 266 $4K
90651 <1% 726 $4K
82627 <1% 170 $3K
01400 <1% 42 $3K
85018 <1% 1,639 $3K
J1940 Injection, furosemide, up to 20 mg <1% 1,998 $3K
83521 <1% 304 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 125 $3K
73552 <1% 107 $3K
84630 <1% 409 $3K
83540 <1% 542 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 188 $3K
86787 <1% 352 $3K
84520 <1% 782 $3K
99177 <1% 834 $3K
51702 <1% 57 $3K
90632 <1% 84 $3K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 906 $3K
72052 <1% 32 $3K
81511 <1% 29 $3K
84460 <1% 881 $3K
86617 <1% 256 $3K
82330 <1% 475 $3K
97163 <1% 38 $3K
80177 <1% 261 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 403 $3K
94664 <1% 236 $3K
A9270 Non-covered item or service <1% 5,083 $2K
86334 <1% 172 $2K
98966 <1% 1,035 $2K
J9263 Injection, oxaliplatin, 0.5 mg <1% 150 $2K
86381 <1% 156 $2K
87486 <1% 161 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,121 $2K
74220 <1% 13 $2K
77012 <1% 13 $2K
80202 <1% 185 $2K
86682 <1% 205 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,856 $2K
90633 <1% 2,537 $2K
92611 <1% 28 $2K
82652 <1% 58 $2K
85520 <1% 138 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 12 $2K
86666 <1% 207 $2K
80171 <1% 92 $2K
80346 <1% 180 $2K
91322 <1% 42 $2K
C9113 Injection, pantoprazole sodium, per vial <1% 1,132 $2K
80361 <1% 187 $2K
Q3014 Telehealth originating site facility fee <1% 3,485 $2K
80349 <1% 112 $2K
73100 <1% 28 $2K
J1953 Injection, levetiracetam, 10 mg <1% 372 $2K
88184 <1% 90 $2K
87517 <1% 61 $2K
90480 <1% 68 $2K
98941 Chiropractic manipulative treatment; spinal, 3-4 regions <1% 126 $2K
90723 <1% 3,013 $2K
92610 <1% 46 $2K
73600 <1% 32 $2K
85384 <1% 376 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 756 $2K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 19 $2K
99381 <1% 41 $2K
87536 <1% 31 $1K
90697 <1% 1,533 $1K
88142 <1% 90 $1K
99195 <1% 46 $1K
88312 <1% 26 $1K
90658 <1% 293 $1K
81241 <1% 57 $1K
85014 <1% 510 $1K
89051 <1% 323 $1K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 637 $1K
97164 <1% 52 $1K
86015 <1% 140 $1K
90734 <1% 700 $1K
87449 <1% 84 $1K
90648 <1% 3,049 $1K
96161 <1% 702 $1K
99336 <1% 37 $1K
86359 <1% 48 $1K
96401 <1% 82 $1K
90677 <1% 1,417 $1K
90681 <1% 834 $1K
82390 <1% 138 $1K
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units <1% 1,422 $1K
99462 <1% 43 $1K
70150 <1% 13 $1K
73660 <1% 32 $1K
92579 <1% 15 $1K
82951 <1% 108 $1K
97165 <1% 39 $1K
82365 <1% 123 $1K
80197 <1% 125 $999.52
C1788 Port, indwelling (implantable) <1% 18 $992.72
82653 <1% 13 $955.10
86694 <1% 75 $946.49
82672 <1% 71 $946.00
90674 <1% 90 $925.05
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 105 $907.09
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 38 $904.86
82671 <1% 37 $890.27
98940 <1% 92 $881.59
85613 <1% 139 $838.48
86318 <1% 53 $828.37
J1650 Injection, enoxaparin sodium, 10 mg <1% 134 $827.94
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 12 $824.23
97010 <1% 169 $815.29
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 116 $799.88
90710 <1% 423 $788.20
12011 <1% 28 $729.43
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 218 $710.40
80051 <1% 213 $699.08
99407 <1% 42 $690.86
85390 <1% 88 $675.86
80364 <1% 17 $672.40
J1030 Injection, methylprednisolone acetate, 40 mg <1% 138 $664.06
J3360 Injection, diazepam, up to 5 mg <1% 187 $655.89
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,753 $651.82
97014 <1% 77 $649.14
J2060 Injection, lorazepam, 2 mg <1% 1,674 $635.57
90682 <1% 12 $627.15
99221 <1% 32 $623.12
86709 <1% 48 $616.20
J1010 Injection, methylprednisolone acetate, 1 mg <1% 176 $601.88
96402 <1% 23 $570.56
86705 <1% 54 $566.08
86360 <1% 32 $555.27
80324 <1% 19 $508.25
84479 <1% 101 $506.36
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 1,333 $503.70
J1596 Injection, glycopyrrolate, 0.1 mg <1% 385 $485.75
90656 <1% 596 $478.37
86146 <1% 25 $442.78
84300 <1% 148 $440.05
86580 <1% 99 $434.30
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 463 $423.19
80359 <1% 13 $413.52
94667 <1% 29 $401.27
87625 <1% 37 $396.14
84450 <1% 131 $387.22
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 161 $378.69
86738 <1% 56 $374.73
85347 <1% 48 $367.37
D1206 Topical application of fluoride varnish <1% 29 $360.00
84157 <1% 92 $346.48
84155 <1% 172 $345.72
99318 <1% 89 $344.35
90732 <1% 12 $342.40
82952 <1% 107 $337.76
J2806 Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms <1% 12 $301.49
72020 <1% 15 $299.12
82595 <1% 49 $287.70
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 1,065 $275.58
87324 <1% 63 $273.95
85246 <1% 12 $271.84
J0735 Injection, clonidine hydrochloride, 1 mg <1% 94 $262.67
80368 <1% 13 $250.44
J2470 Injection, pantoprazole sodium, 40 mg <1% 218 $249.79
85240 <1% 15 $230.02
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) <1% 14 $205.75
85045 <1% 79 $201.56
82787 <1% 21 $190.28
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 29 $170.60
83630 <1% 21 $170.18
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 70 $164.43
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 28 $162.63
90680 <1% 865 $160.90
90716 <1% 40 $154.61
80365 <1% 27 $144.90
90696 <1% 157 $144.00
85397 <1% 12 $142.94
90472 Immunization administration, each additional vaccine (list separately) <1% 12 $141.50
J1171 Injection, hydromorphone, 0.1 mg <1% 134 $134.51
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 515 $132.61
99232 Hospital visit by a doctor, follow-up day <1% 32 $122.82
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 95 $116.92
86431 <1% 31 $114.97
86316 <1% 13 $111.44
86735 <1% 13 $100.48
80178 <1% 26 $99.36
84311 <1% 48 $97.69
80175 <1% 13 $97.59
90647 <1% 464 $96.89
90707 <1% 40 $90.94
J0592 Injection, buprenorphine hydrochloride, 0.1 mg <1% 49 $90.25
A9284 Spirometer, non-electronic, includes all accessories <1% 28 $83.76
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 20 $83.32
29126 <1% 15 $81.62
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 13 $81.20
83721 <1% 18 $76.69
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 33 $75.16
J1630 Injection, haloperidol, up to 5 mg <1% 278 $72.53
J0595 Injection, butorphanol tartrate, 1 mg <1% 123 $70.91
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) <1% 651 $66.79
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 115 $65.13
81002 <1% 56 $57.78
83935 <1% 13 $57.60
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 459 $54.65
90687 <1% 78 $50.36
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 129 $49.22
94760 <1% 25 $47.44
99348 <1% 15 $47.32
94644 <1% 17 $46.21
36416 <1% 60 $37.21
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg <1% 189 $17.39
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 49 $14.90
G0008 Administration of influenza virus vaccine <1% 308 $11.93
Q0247 Injection, sotrovimab, 500 mg <1% 41 $4.91
90700 <1% 62 $3.64
Q0222 Injection, bebtelovimab, 175 mg <1% 34 $3.07
3078F 0% 4,746 $0.00
3077F 0% 610 $0.00
3725F 0% 26 $0.00
90380 0% 12 $0.00
3074F 0% 5,386 $0.00
3079F 0% 4,481 $0.00
3080F 0% 126 $0.00
1126F 0% 54 $0.00
3075F 0% 2,094 $0.00
1111F 0% 32 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 0% 14 $0.00
90381 0% 28 $0.00
99335 0% 53 $0.00
95115 0% 53 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARKS, SARA (CEO)
Same official

Other billing entities under MARKS, SARA

Full network →
ProviderLocationPaid
Kings Daughters Medical Specialties INC.Ashland, KY$6.34M
Ashland Hospital CorporationAshland, KY$1.59M
Kings Daughters Medical Specialties INCAshland, KY$1.46M
Ashland Hospital CorporationJackson, OH$722K
King's Daughters Medical Specialties, INC.Ashland, KY$509K
Kings Daughters Medcial Specialties INCAshland, KY$383K
King's Daughters Medical Specialties, INC.Ashland, KY$297K
Ashland Hospital CorporationAshland, KY$296K
Kings Daughters Medical Specialties INC.,Portsmouth, OH$169K
Kings Daughters Medical Specialties INCPrestonsburg, KY$127K
Kings Daughters Medical Specialties INC.,Ashland, KY$108K
Kings Daughters Medical Specialties INCAshland, KY$101K
Ashland Hospital CorporationIronton, OH$69K
Ashland Hospital CorporationAshland, KY$53K
Kings Daughters Medical Specialties INCAshland, KY$41K
Ashland Hospital CorporationPaintsville, KY$11K
King's Daughters Medical Specialties, INC.Portsmouth, OH$9K
Ashland Hospital CoporationAshland, KY$7K
Ashalnd Hospital CorporationAshland, KY$5K
Ashland Hospital CoporationAshland, KY$5K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.